However, considering the substantial contribution of local and systemic inflammation to the advancement of malignant tumors and its role in cancer progression and the survival of patients with cancer, it is plausible to suggest that the inflammation-induced PD-1/PD-L1 pathway might play a role in the development of pancreatic endocrine dysfunction (17, 18). Here, CD274 is linked to cancer.